Pharmabiz57m
Uganda’s Ministry of Health, WHO and other partners launch Ebola vaccination trial in Uganda
Uganda’s Ministry of Health, WHO and other partners launch Ebola vaccination trial in Uganda: Geneva Wednesday, February 5, 2025, 09:00 Hrs [IST] In a global first, Uganda’s M ...
Pharmabiz1h
Generic Aadhaar to expand network to 5,000 stores across India by end of 2025
Generic Aadhaar to expand network to 5,000 stores across India by end of 2025: Peethaambaran Kunnathoor, Chennai Wednesday, February 5, 2025, 08:00 Hrs [IST] The Mumbai-based gene ...
Pharmabiz1h
Indian pharma eyes anticancer research investment as drug innovation to propel future growth
Indian pharma eyes anticancer research investment as drug innovation to propel future growth: Nandita Vijayasimha, Bengaluru Wednesday, February 5, 2025, 08:00 Hrs [IST] Indian ph ...
Pharmabiz1h
A GOOD BUDGET FOR HEALTHCARE SECTOR
In the Union Budget 2025, Union Finance Minister Nirmala Sitharaman has announced a slew of good initiatives for the healthcare sector in the country. In her eighth consecutive Union Budget ...
Pharmabiz1h
Exporters disappointed as Budget 2025 fails to address Section 43B(h) waiver demand
Exporters disappointed as Budget 2025 fails to address Section 43B(h) waiver demand: Shardul Nautiyal, Mumbai Wednesday, February 5, 2025, 08:00 Hrs [IST] India's pharmaceutical e ...
Pharmabiz1h
Budget allocation to Ministry of Ayush to go up 7.6% in FY26
The Union Budget 2025-26 proposes to allocate around Rs. 3,993 crore for the Ministry of Ayush, around 7.6 per cent higher than the Rs. 3,712.5 crore Budget Estimates (BE) for the fiscal 2024-25. The ...
Pharmabiz1h
No ban on methylcobalamin in health supplements & nutraceutical products: Health ministry
No ban on methylcobalamin in health supplements & nutraceutical products: Health ministry: Shardul Nautiyal, Mumbai Wednesday, February 5, 2025, 08:00 Hrs [IST] The Union health m ...
Pharmabiz17h
Aplagon announces EUR 7 million financing to advance its APAC therapeutic for thrombo-inflammatory diseases into phase 2A trials
Aplagon announces EUR 7 million financing to advance its APAC therapeutic for thrombo-inflammatory diseases into phase 2A trials: Helsinki Tuesday, February 4, 2025, 16:00 Hrs [IS ...
Pharmabiz18h
EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC
EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC: Beerse, Belgium Tuesday, February ...
Pharmabiz21h
Lilly India appoints Winselow Tucker as president and general manager
Lilly India appoints Winselow Tucker as president and general manager: Our Bureau, Mumbai Tuesday, February 4, 2025, 12:15 ...
Pharmabiz20h
Sanofi announces buy back of shares from L’Oréal
Sanofi, an innovative global healthcare company, announces the acquisition of 2.3 per cent of its shares from long-standing shareholder L’Oréal. This transaction is part of Sanofi’s share buyback ...
Pharmabiz18h
Third EC meeting of CIPI will be held in Chennai on February 8, latest issues in pharma industries will be discussed
Third EC meeting of CIPI will be held in Chennai on February 8, latest issues in pharma industries will be discussed: Our Bureau, Chennai Tuesday, February 4, 2025, 15:15 Hrs [IST ...